Gregory K. Chow insider trades
Open-market stock purchases and sales by Gregory K. Chow, CFO at Sutro Biopharma, Inc, from SEC Form 4 filings since Jan 2, 2019.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -4%.
Open-market stock purchases and sales by Gregory K. Chow, CFO at Sutro Biopharma, Inc, from SEC Form 4 filings since Jan 2, 2019.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -4%.